Financial
FY2026 revenue A$94.2m (+16.0%); net margin 9.6%; net income A$9.0m.
EBITDA A$14.9m (+14%); NPAT up 52%.
HQ Australia · Asia-Pacific
Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.
FY2026 revenue A$94.2m (+16.0%); net margin 9.6%; net income A$9.0m.
EBITDA A$14.9m (+14%); NPAT up 52%.
Source: official results release · Year ended 2026-06-30 · Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.
| Year | Revenue | Growth | Operating profit | Net income | Covers |
|---|---|---|---|---|---|
| FY2026 | A$94.2m | +16.0% | — | A$9m | Austco Healthcare |
Products not yet catalogued.
FY2026 revenue A$94.2m (+16.0%); net margin 9.6%; net income A$9.0m.
EBITDA A$14.9m (+14%); NPAT up 52%.
Jun 2026: In an FY26 trading update Austco reported higher logistics costs, longer component lead times and some delayed installations, which it said shift revenue to later periods rather than lose it; it guided revenue up 11–17%.
No data breaches, cyber incidents, regulator actions or published product vulnerabilities involving Austco found in HSH's search of the last 24 months. NHS DSPT status not yet checked.
No product recalls, safety notices or clinical safety actions involving Austco's nurse call products found in HSH's search of the last 24 months.
Jun 2026: Austco reported a contract with its largest US customer to deploy Pulse Mobile across about 180 hospitals in 2026, and contracted backlog of A$47.2m; in Mar 2025 it signed a five-year support agreement with West Park Hospital, Toronto.
No competitors linked yet.